The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.2 - Manufacture of pharmaceutical preparations
154 jobs Number of planned job losses
Announcement Date
25 January 2023
Employment effect (start)
30 April 2023
Foreseen end date
Description
Janssen Pharmaceutica, the Belgian branch of the multinational Johnson & Johnson group has announced it will dismiss between 185 and 200 employees within its Belgian division. The job cuts will take place in the research and development department.
According to the company management, the planned layoffs are partly caused by the current economic conditions. As the management expects these conditions to deteriorate further in the future.
Trade unions are surprised by the decision of the company management as there were few indications that such a decision was at hand. It is also very rare within the company that this many people are dismissed at once.
Update 30/03/2023
The number of dismissals was reduced after negotiations with the trade unions as is stipulated by the Renault Law. Leading to 154 dismissals in total.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
